CEMER Centro Médico de Enfermedades Respiratorias - Vicente Lopez

CEMER Centro Médico de Enfermedades Respiratorias - Vicente Lopez
Esmeralda 1550, Vicente Lopez, Buenos Aires
Select an option

Our team

Medical staff
Gabriela Tabaj
Erik Silva
Gustavo Lopez
Cristian Micheri
Miguel Angel Bergna
Nicolás Porta
Carolina Kreimis
Amparo Martinez Ferro

Open studies

Asthma
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma - FLASH - AstraZenecaSee more
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. - EXHALE-2 - Areteia TherapeuticsSee more
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma - AmgenSee more
Lung cancer
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment - SAFFRON - AstraZenecaSee more
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) - GALAXIES Lung-301 - GlaxoSmithKlineSee more
Pulmonary fibrosis
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis - ALOFT-IPF - Bristol-Myers SquibbSee more
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis - ALOFT-PPF - Bristol-Myers SquibbSee more
Chronic obstructive pulmonary disease
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease - THARROS - AstraZenecaSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy